Literature DB >> 26002550

Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.

Zhang Jing1, Chang Chun2, Shen Ning1, Zhu Hong1, He Bei1, Yao Wan-Zhen1.   

Abstract

INTRODUCTION: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) readmission contributes considerably to the worse outcomes for COPD patients. Predictors for readmission include some socio-demographic variables and the severity of the underlying disease, however, few evidence suggested whether persistently heightened airway or systemic inflammation was related to recurrence of AECOPD. The aim of this study was to evaluate role of airway and systemic inflammatory biomarkers during AECOPD on predicting readmission for AECOPD.
METHODS: Consecutive hospitalized patients with AECOPD were recruited. Inflammatory and clinical indices were evaluated at the day of admission before starting therapy and the day of planned discharge (day 10-14). Predictors for readmission were assessed by binary logistic regression model.
RESULTS: 93 patients were included with 51 patients (54.8%) were readmitted due to AECOPD at least once during 1 year following the index admission. The logistic regression model indicated that age (OR=1.072, 95%CI: 1.012-1.135, P=.017), hs-CRP (high sensitive-C reactive protein) at day 14 (OR=1.392, 95%CI: 1.131-1.712, P=.002), CAT value at day 14 (OR=1.12, 95%CI: 1.031-1.217, P=.007) were the independent variables statistically significant in predicting rehospitalization.
CONCLUSION: Systemic inflammatory marker CRP was a better predictor of readmission than sputum inflammatory markers. CAT score and age were also useful to predict readmission.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Estado de salud; Exacerbaciones agudas de enfermedad pulmonar obstructiva crónica; Exacerbation of chronic obstructive pulmonary disease; Factor inflamatorio; Health status; Inflammatory factor; Rehospitalización; Rehospitalization

Mesh:

Substances:

Year:  2015        PMID: 26002550     DOI: 10.1016/j.arbres.2015.01.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  8 in total

1.  Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.

Authors:  Daniel J Weiss; Karen Segal; Richard Casaburi; Jack Hayes; Donald Tashkin
Journal:  Respir Res       Date:  2021-05-08

2.  The Impact of Community-acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients as Regards In-hospital Complications and Early Readmission.

Authors:  Dina Ruby
Journal:  Open Respir Med J       Date:  2020-04-09

3.  Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.

Authors:  Diandian Li; Yanqiu Wu; Shujin Guo; Jiangyue Qin; Mei Feng; Yunfei An; Junlong Zhang; Yanping Li; Shuguang Xiong; Hui Zhou; Qianglin Zeng; Lei Chen; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-28

4.  Immune Characteristics Analysis and Transcriptional Regulation Prediction Based on Gene Signatures of Chronic Obstructive Pulmonary Disease.

Authors:  Hui Yu; Weikang Guo; Yunduo Liu; Yaoxian Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-05

5.  Prediction of gold stage in patients hospitalized with COPD exacerbations using blood neutrophils and demographic parameters as risk factors.

Authors:  Jing Chen; Zhao Yang; Qun Yuan; Li-Quan Guo; Da-Xi Xiong
Journal:  BMC Pulm Med       Date:  2021-10-21       Impact factor: 3.317

6.  Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge.

Authors:  Lili Chen; Shiping Chen
Journal:  BMC Pulm Med       Date:  2021-10-15       Impact factor: 3.317

7.  The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.

Authors:  Dildar Duman; Emine Aksoy; Meltem Coban Agca; Nagihan Durmus Kocak; Ipek Ozmen; Ulku Aka Akturk; Sinem Gungor; Fatma Merve Tepetam; Selma Aydogan Eroglu; Selahattin Oztas; Zuhal Karakurt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-11

8.  Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.

Authors:  Alexa Nuñez; Viviana Marras; Matevz Harlander; Evgeni Mekov; Cristina Esquinas; Matjaz Turel; David Lestan; Rosen Petkov; Nikolay Yanev; Pietro Pirina; Silvia Negri; Marc Miravitlles; Miriam Barrecheguren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.